Cadaver kidney transplantation in the north Italy transplant program in the nineties.

G. Sirchia, L. Mascaretti, F. Poli, M. Scalamogna, M. Pappalettera, C. Pizzi

Research output: Contribution to journalArticle

Abstract

The most relevant changes which have taken place in the NITp in the nineties include the introduction of HLA-DRB1 matching, the extension of both recipient and donor selection criteria, and an increase in donor procurement and consequently, in transplantation activity. Some of the changes in policy resulted from extensive analysis of our previous experience. For the future years, the NITp has set the following priorities: Consolidate the increase of donor procurement activity registered in the past 15 months by educational campaigns for health workers and the public, and organizational measures aimed at strengthening ICUs, nominating transplant coordinators and introducing a system of reimbursement for organs procured. Improve the quality of results in terms of patient rehabilitation and cost-benefit through: continued evaluation of protocols for patient admission on the waiting lists and careful selection of donors; and prospective use of genomic HLA Class II matching and also consider genomic typing for HLA Class I which is almost a reality. Establish a single pool of patients on the waiting list evaluated according to common protocols with the possibility of performing the transplant in each of the authorized centers in turn, respecting the best HLA match and the local use of organs. Finally, standards for donor treatment, organ procurement, histocompatibility testing and transplantation must be established. For this purpose, accreditation programs which have begun to be applied in Europe seem to be the adequate tool.

Original languageEnglish
Pages (from-to)241-254
Number of pages14
JournalClinical transplants
Publication statusPublished - 1995

Fingerprint

Cadaver
Kidney Transplantation
Italy
Donor Selection
Histocompatibility Testing
Waiting Lists
Tissue Donors
Transplants
Transplantation
HLA-DRB1 Chains
Tissue and Organ Procurement
Accreditation
Patient Admission
Health Promotion
Patient Selection
Cost-Benefit Analysis
Rehabilitation
Public Health
Therapeutics

Cite this

Sirchia, G., Mascaretti, L., Poli, F., Scalamogna, M., Pappalettera, M., & Pizzi, C. (1995). Cadaver kidney transplantation in the north Italy transplant program in the nineties. Clinical transplants, 241-254.

Cadaver kidney transplantation in the north Italy transplant program in the nineties. / Sirchia, G.; Mascaretti, L.; Poli, F.; Scalamogna, M.; Pappalettera, M.; Pizzi, C.

In: Clinical transplants, 1995, p. 241-254.

Research output: Contribution to journalArticle

Sirchia, G, Mascaretti, L, Poli, F, Scalamogna, M, Pappalettera, M & Pizzi, C 1995, 'Cadaver kidney transplantation in the north Italy transplant program in the nineties.', Clinical transplants, pp. 241-254.
Sirchia G, Mascaretti L, Poli F, Scalamogna M, Pappalettera M, Pizzi C. Cadaver kidney transplantation in the north Italy transplant program in the nineties. Clinical transplants. 1995;241-254.
Sirchia, G. ; Mascaretti, L. ; Poli, F. ; Scalamogna, M. ; Pappalettera, M. ; Pizzi, C. / Cadaver kidney transplantation in the north Italy transplant program in the nineties. In: Clinical transplants. 1995 ; pp. 241-254.
@article{14035bd731274f7480afddaae1fefe27,
title = "Cadaver kidney transplantation in the north Italy transplant program in the nineties.",
abstract = "The most relevant changes which have taken place in the NITp in the nineties include the introduction of HLA-DRB1 matching, the extension of both recipient and donor selection criteria, and an increase in donor procurement and consequently, in transplantation activity. Some of the changes in policy resulted from extensive analysis of our previous experience. For the future years, the NITp has set the following priorities: Consolidate the increase of donor procurement activity registered in the past 15 months by educational campaigns for health workers and the public, and organizational measures aimed at strengthening ICUs, nominating transplant coordinators and introducing a system of reimbursement for organs procured. Improve the quality of results in terms of patient rehabilitation and cost-benefit through: continued evaluation of protocols for patient admission on the waiting lists and careful selection of donors; and prospective use of genomic HLA Class II matching and also consider genomic typing for HLA Class I which is almost a reality. Establish a single pool of patients on the waiting list evaluated according to common protocols with the possibility of performing the transplant in each of the authorized centers in turn, respecting the best HLA match and the local use of organs. Finally, standards for donor treatment, organ procurement, histocompatibility testing and transplantation must be established. For this purpose, accreditation programs which have begun to be applied in Europe seem to be the adequate tool.",
author = "G. Sirchia and L. Mascaretti and F. Poli and M. Scalamogna and M. Pappalettera and C. Pizzi",
year = "1995",
language = "English",
pages = "241--254",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Cadaver kidney transplantation in the north Italy transplant program in the nineties.

AU - Sirchia, G.

AU - Mascaretti, L.

AU - Poli, F.

AU - Scalamogna, M.

AU - Pappalettera, M.

AU - Pizzi, C.

PY - 1995

Y1 - 1995

N2 - The most relevant changes which have taken place in the NITp in the nineties include the introduction of HLA-DRB1 matching, the extension of both recipient and donor selection criteria, and an increase in donor procurement and consequently, in transplantation activity. Some of the changes in policy resulted from extensive analysis of our previous experience. For the future years, the NITp has set the following priorities: Consolidate the increase of donor procurement activity registered in the past 15 months by educational campaigns for health workers and the public, and organizational measures aimed at strengthening ICUs, nominating transplant coordinators and introducing a system of reimbursement for organs procured. Improve the quality of results in terms of patient rehabilitation and cost-benefit through: continued evaluation of protocols for patient admission on the waiting lists and careful selection of donors; and prospective use of genomic HLA Class II matching and also consider genomic typing for HLA Class I which is almost a reality. Establish a single pool of patients on the waiting list evaluated according to common protocols with the possibility of performing the transplant in each of the authorized centers in turn, respecting the best HLA match and the local use of organs. Finally, standards for donor treatment, organ procurement, histocompatibility testing and transplantation must be established. For this purpose, accreditation programs which have begun to be applied in Europe seem to be the adequate tool.

AB - The most relevant changes which have taken place in the NITp in the nineties include the introduction of HLA-DRB1 matching, the extension of both recipient and donor selection criteria, and an increase in donor procurement and consequently, in transplantation activity. Some of the changes in policy resulted from extensive analysis of our previous experience. For the future years, the NITp has set the following priorities: Consolidate the increase of donor procurement activity registered in the past 15 months by educational campaigns for health workers and the public, and organizational measures aimed at strengthening ICUs, nominating transplant coordinators and introducing a system of reimbursement for organs procured. Improve the quality of results in terms of patient rehabilitation and cost-benefit through: continued evaluation of protocols for patient admission on the waiting lists and careful selection of donors; and prospective use of genomic HLA Class II matching and also consider genomic typing for HLA Class I which is almost a reality. Establish a single pool of patients on the waiting list evaluated according to common protocols with the possibility of performing the transplant in each of the authorized centers in turn, respecting the best HLA match and the local use of organs. Finally, standards for donor treatment, organ procurement, histocompatibility testing and transplantation must be established. For this purpose, accreditation programs which have begun to be applied in Europe seem to be the adequate tool.

UR - http://www.scopus.com/inward/record.url?scp=0029440234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029440234&partnerID=8YFLogxK

M3 - Article

C2 - 8794270

AN - SCOPUS:0029440234

SP - 241

EP - 254

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -